What is the FLR stock price forecast for 2026-2027?
The 9 Wall Street analysts covering Fluor Corp. have a median 12-month price target of $66, with estimates ranging from $48 to $71. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is FLR stock a buy right now?
Of the 9 analysts covering Fluor Corp., 4 rate it a Buy, 5 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Fluor Corp. 65 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank FLR?
As at 12 Sept 2026, Fluor Corp. ranks 65 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (86 of 100).
Will FLR stock go up?
No one can know that. What the data says: the median 12-month target from 9 analysts implies +20.8% from the last close, and Ticker Nerd's factor model ranks Fluor Corp. 65 out of 100 as at 12 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the FLR stock forecast for 2030?
No analyst covering Fluor Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for FLR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $48 to $71 over the next 12 months.
How has FLR stock performed over the past year?
Fluor Corp. returned +31.2% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Fluor Corp. do?
Fluor Corporation is a global engineering, procurement, construction, and project management company headquartered in Irving, Texas. Fluor delivers professional and technical services across the full project life cycle, from early-stage design and engineering through construction, fabrication, modularization, operations, maintenance, and asset support.
What is the latest news on FLR?
The most recent item we track (TheNewswire, 10 Sept 2026): "(PODCAST) Voyageur Pharmaceuticals (TSXV:VM) Achieves First Milestone in Bayer Collaboration, Secures USD $1 Million Payment". Voyageur Pharmaceuticals announced it achieved its first milestone under its Collaboration and Funding Agreement with Bayer, with its feasibility work plan and timetable approved by Bayer. This triggered a USD $1,000,000 non-dilutive payment, bringing total Bayer funding received to USD $1,350,000 of a committed USD $2,350,000.